Home/Search
2020 Scientific Sessions
LDL Management for the Interventionalist
Sponsored by SCAI. Supported by Amgen.
The Impact of PCSK-9 Inhibition of Coronary Plaque: GLAGOV and Beyond
Subhash Banerjee, M.D., FSCAI
, Baylor Scott & White Heart and Vascular Hospital - Dallas, Dallas, TX
View Recording
PCSK-9 Inhibition: Clinical Trial Data
Payal Kohli, MD
, Cherry Creek Heart, Denver, CO
View Recording
LDL Management: Guideline Recommendations
Michael H. Davidson, MD
, The University of Chicago Pritzker School of Medicine, Chicago, IL
View Recording
Lipid Lowering in the COVID Era
Thomas Knickelbine, M.D.
, Minneapolis Cardiology Associates, Minneapolis, MN
View Recording
See more of:
Satellite Sessions
<< Previous Satellite
|
Next Satellite >>